{"id":152422,"date":"2022-04-11T04:36:42","date_gmt":"2022-04-11T04:36:42","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=152422"},"modified":"2022-08-16T09:21:20","modified_gmt":"2022-08-16T09:21:20","slug":"oral-hypoglycemic-agent","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/","title":{"rendered":"Oral hypoglycemic agent"},"content":{"rendered":"<p>A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus.<\/p>\n<hr \/>\n<p>Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 diabetes mellitus. Commonly used oral agents for diabetes include metformin (a biguanide), sulfonylureas (e.g., glyburide), alpha glucosidase inhibitors (acarbose), and thiazolidinediones (pioglitazone). Used appropriately, OHAs lower hemoglobin Ale levels by about 0.5 to 1.5%.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus. Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-152422","post","type-post","status-publish","format-standard","hentry","category-o"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Oral hypoglycemic agent - Definition of Oral hypoglycemic agent<\/title>\n<meta name=\"description\" content=\"A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus.Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 diabetes mellitus. Commonly used oral agents for diabetes include metformin (a biguanide), sulfonylureas (e.g., glyburide), alpha glucosidase inhibitors (acarbose), and thiazolidinediones (pioglitazone). Used appropriately, OHAs lower hemoglobin Ale levels by about 0.5 to 1.5%.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oral hypoglycemic agent - Definition of Oral hypoglycemic agent\" \/>\n<meta property=\"og:description\" content=\"A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus.Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 diabetes mellitus. Commonly used oral agents for diabetes include metformin (a biguanide), sulfonylureas (e.g., glyburide), alpha glucosidase inhibitors (acarbose), and thiazolidinediones (pioglitazone). Used appropriately, OHAs lower hemoglobin Ale levels by about 0.5 to 1.5%.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-11T04:36:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-16T09:21:20+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/\",\"name\":\"Oral hypoglycemic agent - Definition of Oral hypoglycemic agent\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-04-11T04:36:42+00:00\",\"dateModified\":\"2022-08-16T09:21:20+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus.Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 diabetes mellitus. Commonly used oral agents for diabetes include metformin (a biguanide), sulfonylureas (e.g., glyburide), alpha glucosidase inhibitors (acarbose), and thiazolidinediones (pioglitazone). Used appropriately, OHAs lower hemoglobin Ale levels by about 0.5 to 1.5%.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oral hypoglycemic agent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oral hypoglycemic agent - Definition of Oral hypoglycemic agent","description":"A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus.Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 diabetes mellitus. Commonly used oral agents for diabetes include metformin (a biguanide), sulfonylureas (e.g., glyburide), alpha glucosidase inhibitors (acarbose), and thiazolidinediones (pioglitazone). Used appropriately, OHAs lower hemoglobin Ale levels by about 0.5 to 1.5%.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/","og_locale":"en_US","og_type":"article","og_title":"Oral hypoglycemic agent - Definition of Oral hypoglycemic agent","og_description":"A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus.Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 diabetes mellitus. Commonly used oral agents for diabetes include metformin (a biguanide), sulfonylureas (e.g., glyburide), alpha glucosidase inhibitors (acarbose), and thiazolidinediones (pioglitazone). Used appropriately, OHAs lower hemoglobin Ale levels by about 0.5 to 1.5%.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/","og_site_name":"Glossary","article_published_time":"2022-04-11T04:36:42+00:00","article_modified_time":"2022-08-16T09:21:20+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/","name":"Oral hypoglycemic agent - Definition of Oral hypoglycemic agent","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-04-11T04:36:42+00:00","dateModified":"2022-08-16T09:21:20+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A drug taken by mouth to help control hyperglycemia in type 2 diabetes mellitus.Any drug taken by mouth that lowers or maintains blood sugar (as opposed to insulin, a drug taken parenterally to control blood sugar). OHAs are typically used, in addition to diet and exercise, to control blood glucose levels in type 2 diabetes mellitus. Commonly used oral agents for diabetes include metformin (a biguanide), sulfonylureas (e.g., glyburide), alpha glucosidase inhibitors (acarbose), and thiazolidinediones (pioglitazone). Used appropriately, OHAs lower hemoglobin Ale levels by about 0.5 to 1.5%.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/oral-hypoglycemic-agent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Oral hypoglycemic agent"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/152422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=152422"}],"version-history":[{"count":2,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/152422\/revisions"}],"predecessor-version":[{"id":176966,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/152422\/revisions\/176966"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=152422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=152422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=152422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}